Pharmafile Logo

Peter Impey

Patient Centricity: Turning Rhetoric into Reality

Live webinar: Thursday 30th March 10:00 EDT / 15:00 BST / 16:00 CEST

Inizio

AstraZeneca AZ

FDA turns down AZ’s ZS-9 once again on manufacturing issues

The regulator says it can resubmit the application once deficiencies are tackled

- PMLiVE

Grünenthal’s relentless pursuit of relief

New CEO Gabriel Baertschi on putting pain in the crosshairs of innovation

Biogen Idec building

NICE backtracks on Biogen’s multiple sclerosis drug Zinbryta

Recommends the treatment after new cost effectiveness and a discount provided

Polyphor appoints new chief medical and development officer

Dr Debra Baker joins the firm from Novartis

Sanofi to develop a mobile app for insulin patients

Will work with therapeutic companion software company Voluntis

- PMLiVE

Simon Pickup joins Concentric Health Experience London

Takes up managing director role at the healthcare advertising agency

- PMLiVE

Assessing early market opportunity

To successfully develop and launch an asset it’s crucial to identify and define the commercial value early in the process.

- PMLiVE

Type 2 diabetes can be reversed in just four months, say researchers

A controlled diet and a strict exercise regime could help cure type 2 diabetes

- PMLiVE

The potential of programmatic

Consumers desire messages which are personalised and relevant to their needs

National Institute for Health and Care Excellence NICE logo

NICE agrees £20m cost ceiling for new drugs

New budget test set to begin from April and could delay uptake of new medicines

- PMLiVE

La La Land? The myth of multichannel excellence

Pharma is still experiencing growing pains in multichannel marketing

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links